资源中心

Engineered T cell therapy for the treatment of cardiac fibrosis during chronic phase of myocarditis

发布时间：

1970-01-01

Hua X, Sun Z, Liang Z, Huang Y, Mo H, Dong F, Mo S, Yang X, Zhang N, Chen X, Liao S, Qi Z, Zhang R, Guan S, Li L, Xu Y, Song J. Engineered T cell therapy for the treatment of cardiac fibrosis during chronic phase of myocarditis. Theranostics. 2026 Jan 1;16(4):2037-2051. doi: 10.7150/thno.116749.

上一个

Magnoflorine attenuates Ang II-induced cardiac remodeling via promoting AMPK-regulated autophagy

无

下一个

上一个：

Magnoflorine attenuates Ang II-induced cardiac remodeling via promoting AMPK-regulated autophagy

下一个：

无

活动中心

α-myosin heavy chain lactylation maintains sarcomeric structure and function and alleviates the development of heart failure

1970-01-01

BAF155 promotes cardiac hypertrophy and fibrosis through inhibition of WWP2-mediated PARP1 ubiquitination

1970-01-01

Piezo1-Mediated Neurogenic Inflammatory Cascade Exacerbates Ventricular Remodeling After Myocardial Infarction

1970-01-01

Ultrasound-triggered microbubble destruction enhances the radiosensitivity of glioblastoma by inhibiting PGRMC1-mediated autophagy in vitro and in vivo

1970-01-01

Treatment of infarcted heart tissue via the capture and local delivery of circulating exosomes through antibody-conjugated magnetic nanoparticles

1970-01-01

Construction of tissue-engineered vascular grafts with enhanced patency by integrating heparin, cell-adhesive peptide, and carbon monoxide nanogenerators into acellular blood vessels

1970-01-01

分享到

返回列表